August 26, 2014 — Toshiba America Medical Systems’ MR (magnetic resonance) systems have received approval to operate (ATO) with the U.S. Air Force. This makes Toshiba the only manufacturer to have fully certified MR systems (Vantage Titan 1.5T and Vantage Titan 3T) for use on the Air Force Network.

August 26, 2014 — The quality of cardiac rehabilitation programs across Canada is strong, with specific criteria areas now identified as requiring further enhancement to improve patient outcomes, according to a new study conducted by researchers at the Peter Munk Cardiac Center, York University and the University Health Network (UHN).

The mantra for treatment for high blood pressure has been "the lower, the better," but that goal can potentially put patients at risk of kidney failure or death, according to a Kaiser Permanente study published in the Journal of the American College of Cardiology.

A new therapy developed by researchers at the University of South Florida (USF) Morsani College of Medicine and Columbia University Medical Center (CUMC) may help reduce the life-threatening complications of interventional cardiovascular disease treatment.

 

Esaote is launching MyLab Six, a fast, accurate and highly flexible enhanced ultrasound system at ESC (European Society of Cardiology) in Barcelona, to be held Aug. 30 to Sept. 3. Configured for an extensive range of applications, MyLab Six delivers a premium quality, yet affordable, solution for shared ultrasound services across any busy clinical setting.

New data revealing the reduction in cardiovascular (CV) deaths with Novartis' LCZ696 in patients with heart failure with reduced ejection fraction (HF-REF) will be presented at the world's largest cardiology congress, the European Society of Cardiology (ESC) Congress 2014, on Sunday, Aug. 31 at 2:30 a.m. EDT.

Esaote is launching MyLab Gamma, a best-in-class, highly portable “green” cardiovascular ultrasound system at ESC Congress (European Society of Cardiology, Barcelona, Aug. 30-Sept. 3). 

Subscribe Now